包头医学院学报
包頭醫學院學報
포두의학원학보
Journal of Baotou Medical College
2015年
11期
23-24
,共2页
帕瑞昔布钠%右美托咪定%老年%术后认知功能障碍
帕瑞昔佈鈉%右美託咪定%老年%術後認知功能障礙
파서석포납%우미탁미정%노년%술후인지공능장애
Parecoxib sodium%Dexmedetomidine%Elderly patients%Postoperative cognitive dysfunction
目的:对比研究帕瑞昔布钠及右美托咪定对老年病人腹部手术后早期认知功能的影响. 方法:90例择期全麻下行开腹手术的老年患者,随机分为帕瑞昔布钠组、右美托咪定组和生理盐水组,每组30例患者. 帕瑞昔布纳组于麻醉诱导后静脉注射帕瑞昔布钠40 mg;右美托咪定组于气管插管后静脉持续泵入右美托咪定0. 3 μg/(kg·h);生理盐水组静脉注射等量生理盐水. 采用简易精神状态量表( the Mini Mental State Examination,MMSE)分别于手术前1 d、术后第1 d、3 d、7 d测定患者认知功能评分. 结果:与术前比较,术后第1 d、3 d时,3组患者MMSE评分均降低( P <0. 05),生理盐水组患者术后第1 d、3 d时MMSE评分低于帕瑞昔布纳组和右美托咪定组( P <0. 05). 生理盐水组术后认知功能障碍发生率高于帕瑞昔布纳组和右美托咪定组( P <0. 05). MMSE评分及认知功能障碍发生率在帕瑞昔布纳组和右美托咪定组间比较差异无统计学意义. 结论:帕瑞昔布钠及右美托咪定均能降低老年患者腹部手术后早期认知功能障碍的发生率,两者间比较效果相似.
目的:對比研究帕瑞昔佈鈉及右美託咪定對老年病人腹部手術後早期認知功能的影響. 方法:90例擇期全痳下行開腹手術的老年患者,隨機分為帕瑞昔佈鈉組、右美託咪定組和生理鹽水組,每組30例患者. 帕瑞昔佈納組于痳醉誘導後靜脈註射帕瑞昔佈鈉40 mg;右美託咪定組于氣管插管後靜脈持續泵入右美託咪定0. 3 μg/(kg·h);生理鹽水組靜脈註射等量生理鹽水. 採用簡易精神狀態量錶( the Mini Mental State Examination,MMSE)分彆于手術前1 d、術後第1 d、3 d、7 d測定患者認知功能評分. 結果:與術前比較,術後第1 d、3 d時,3組患者MMSE評分均降低( P <0. 05),生理鹽水組患者術後第1 d、3 d時MMSE評分低于帕瑞昔佈納組和右美託咪定組( P <0. 05). 生理鹽水組術後認知功能障礙髮生率高于帕瑞昔佈納組和右美託咪定組( P <0. 05). MMSE評分及認知功能障礙髮生率在帕瑞昔佈納組和右美託咪定組間比較差異無統計學意義. 結論:帕瑞昔佈鈉及右美託咪定均能降低老年患者腹部手術後早期認知功能障礙的髮生率,兩者間比較效果相似.
목적:대비연구파서석포납급우미탁미정대노년병인복부수술후조기인지공능적영향. 방법:90례택기전마하행개복수술적노년환자,수궤분위파서석포납조、우미탁미정조화생리염수조,매조30례환자. 파서석포납조우마취유도후정맥주사파서석포납40 mg;우미탁미정조우기관삽관후정맥지속빙입우미탁미정0. 3 μg/(kg·h);생리염수조정맥주사등량생리염수. 채용간역정신상태량표( the Mini Mental State Examination,MMSE)분별우수술전1 d、술후제1 d、3 d、7 d측정환자인지공능평분. 결과:여술전비교,술후제1 d、3 d시,3조환자MMSE평분균강저( P <0. 05),생리염수조환자술후제1 d、3 d시MMSE평분저우파서석포납조화우미탁미정조( P <0. 05). 생리염수조술후인지공능장애발생솔고우파서석포납조화우미탁미정조( P <0. 05). MMSE평분급인지공능장애발생솔재파서석포납조화우미탁미정조간비교차이무통계학의의. 결론:파서석포납급우미탁미정균능강저노년환자복부수술후조기인지공능장애적발생솔,량자간비교효과상사.
Objective:To compare and study the effect of parecoxib sodium and dexmedetomidine on early postoperative cognitive function in elderly patients undergoing abdominal surgery. Methods:90 elderly patients scheduled to undergo abdominal surgery under general anesthesia were randomly divided into three groups, with 30 cases in each group. In the parecoxib sodium group ( P group) , 40 mg parecoxib sodium were given intravenously after the induction of anesthesia, and patients in the dexmedetomidine group ( D group) were given continuous infection of 0. 3 μg/(kg·h)dexmedetomidine after intubation while in the saline group (S group) patients were given a single injection of physiological saline. Cognitive function was evaluated 24 hours before anesthesia, on the 1st, 3rd and 7th post-operative day by using Mini Mental State Examination (MMSE) scale. Results:The MNSE scores in the three groups on the 1st and 3rd postoperative day were significantly lower with respect to baseline characteristics ( P <0. 05). The MMSE scores in Group S were signifi-cantly lower than those in Group P and D on the 1st and 3rd postoperative day ( P <0. 05). The incidence of cognitive dysfunction in Group S was significantly higher than those in the other two groups ( P <0. 05). No significant differences were observed in the MMSE scores and incidences of postoperative cognitive dysfunction between Groups P and D. Conclusions:Dexmedetomidine and parecoxib so-dium have the comparably similar effect in decreasing the incidence of early cognitive dysfunction in elderly patients undergoing abdominal surgery under general anesthesia.